These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2562579)
21. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response]. Spasokukotskiĭ AL Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565 [TBL] [Abstract][Full Text] [Related]
22. BCG immunotherapy: effects of dose and route of administration in mice bearing established tumors. Codish SD; Monaco AP Surg Forum; 1976; 27(62):150-2. PubMed ID: 1019836 [No Abstract] [Full Text] [Related]
23. Stimulation of tumor growth in mice by high doses of BCG. Kaledin VI; Kurunov YN; Matienko NA; Nikolin VP J Natl Cancer Inst; 1978 Dec; 61(6):1393-6. PubMed ID: 364150 [TBL] [Abstract][Full Text] [Related]
24. [Effects of indomethacin and BCG vaccine on growth of transplanted tumors in mice]. Kurunov IuN; Kaledin VI Eksp Onkol; 1990; 12(6):57-9. PubMed ID: 2261880 [TBL] [Abstract][Full Text] [Related]
25. [Experimental investigations of the optimal therapy of systemic BCG infection in vivo]. Jurczok A; Zacharias M; Böhle A; Fornara P; Jocham D Aktuelle Urol; 2004 Sep; 35(5):406-12. PubMed ID: 15368130 [TBL] [Abstract][Full Text] [Related]
26. [Suppression of tumor growth by the intradermal inoculation of tumor cells and BCG in mice]. Tanaka T; Tokunaga T; Kataoka T; Nakamura R Igaku To Seibutsugaku; 1971 Dec; 83(6):347-51. PubMed ID: 5170204 [No Abstract] [Full Text] [Related]
27. [Experimental study on local immunochemotherapy]. Kasuga M; Sakita M; Yamane T; Torii T; Imai H; Kageyama N; Fujita Y; Majima S Gan To Kagaku Ryoho; 1982 Dec; 9(12):2113-21. PubMed ID: 6820889 [TBL] [Abstract][Full Text] [Related]
28. [Growth of transplantable Guérin tumor and Morris hepatoma in rats after a single dose of BCG vaccine according to different timetables]. Nowak HF; Cylwik B; Zimnoch L; Jodczyk KJ; Pregowski W; Duda D; Bernaczyk A Patol Pol; 1981; 32(2):173-84. PubMed ID: 7322639 [No Abstract] [Full Text] [Related]
29. [Effect of BCG on the growth of Krebs-2 carcinoma]. Kaledin VI; Kurunov IuN Vopr Onkol; 1977; 23(8):60-3. PubMed ID: 906409 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the mode of immunopotentiating action of BCG and wax D. II. Effect on the methylcholanthrene carcinogenesis. Ishibashi T; Yamada H; Harada S; Harada Y; Takamoto M; Sugiyama K Jpn J Exp Med; 1977 Dec; 47(6):435-40. PubMed ID: 609113 [TBL] [Abstract][Full Text] [Related]
31. Neuraminidase treated cells and their role in cancer immunotherapy. Simmons RL; Rios A Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534 [No Abstract] [Full Text] [Related]
33. [The effect of fungal glycoprotein A on tumor growth and survival of C3H strain mice with methylcholanthrene-induced tumors]. Zák M; Novák F; Muiznieks IO; Nikolajeva VR; Kamaradze AA; Maurina HA; Ferdats AK; Jirkovský J Sb Lek; 1988 Sep; 90(8-9):252-9. PubMed ID: 3201088 [No Abstract] [Full Text] [Related]
34. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system. Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416 [TBL] [Abstract][Full Text] [Related]
35. Immuno-therapy of methyl cholanthrene induced and spontaneous tumors in mice by use of tumor vaccine, neuraminidase and BCG. Gautam S; Aikat BK Indian J Med Res; 1976 Mar; 64(3):472-81. PubMed ID: 965048 [No Abstract] [Full Text] [Related]
36. Listeria monocytogenes activated dendritic cell based vaccine for prevention of experimental tumor in mice. Khamisabadi M; Arab S; Motamedi M; Khansari N; Moazzeni SM; Gheflati Z; Hadjati J Iran J Immunol; 2008 Mar; 5(1):36-44. PubMed ID: 18319523 [TBL] [Abstract][Full Text] [Related]
37. The heterogenization of tumour cells with tuberculin. II. Studies of the antigenicity of tuberculin-heterogenized murine tumour cells in syngeneic BCG positive and BCG negative mice. Vyakarnam A; Lachmann PJ; Sikora K Immunology; 1981 Feb; 42(2):337-48. PubMed ID: 6161889 [TBL] [Abstract][Full Text] [Related]
38. Lectin potentiation of BCG-contact-mediated antitumor action. Poduval TB; Seshadri M; Sundaram K J Natl Cancer Inst; 1980 Nov; 65(5):909-12. PubMed ID: 6933260 [TBL] [Abstract][Full Text] [Related]
39. [Effect of combined BCG and UFT therapy of human maxillary cancer transplanted into nude mice]. Saito H; Hozawa J; Mori I; Matsubara A; Tanita J; Fujita S Gan To Kagaku Ryoho; 1988 Sep; 15(9):2751-5. PubMed ID: 3137890 [TBL] [Abstract][Full Text] [Related]
40. [Effect of the joint use of BCG and antithymocyte serum on the growth of a syngeneic tumor in mice]. Babadzhanov AS; Slavina EG Biull Eksp Biol Med; 1983 Feb; 95(2):68-70. PubMed ID: 6600630 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]